… The Health Equity subsection is a refocus of the 2014 guideline’s section guiding management
of high-risk populations. Third, this guideline does not include a separate section on …

This scientific statement is intended for use by physicians and allied health personnel caring
for patients with transient ischemic attacks. Formal evidence review included a structured …

Objective: To assess the efficacy of carotid endarterectomy for stroke prevention in
asymptomatic and symptomatic patients with internal carotid artery stenosis. Additional clinical …

Background and Purpose— This guideline provides an overview of the evidence on established
and emerging risk factors for stroke to provide evidence-based recommendations for …

Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke.
Warfarin is commonly used in preference to aspirin for this disorder, but these therapies have …

… the AHA’s public health campaign for ideal cardiovascular health known as Life’s Simple 7.
As … , and certain risk factors are specific to women’s health (eg, oral contraceptives [OCs] and …

Background— Antithrombotic therapy for intracranial arterial stenosis was recently evaluated
in the Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) trial. A …

Background In the Carotid Revascularization Endarterectomy versus Stenting Trial, we found
no significant difference between the stenting group and the endarterectomy group with …

… Shalini Chaturvedi … Response time of the sensor to trimethylamine is <300 s, and the response
can be … Nakamura I, Negishi N, Kutsuna S, Ihara T, Sugihara S, Takeuch K (2000) J Mol …

Background Previous clinical trials have suggested that carotid-artery stenting with a device
to capture and remove emboli (“embolic protection”) is an effective alternative to carotid …